2022³â ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-05-13±³À°ÀÏÀÚ : 2022-05-13
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
2022³â ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À°ÁÖÃÖ±â°ü : ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ±èÈ«ÀÎ
¿¬¶ôó : 02-6203-2595
À̸ÞÀÏ :
kagp@hanmail.net ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú, ½Å°æ°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 13 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í * µî·Ïºñ(»çÀüµî·Ï) Á¤È¸¿ø Àü¹®ÀÇ 4¸¸¿ø, ºñȸ¿ø Àü¹®°¡ 5¸¸¿ø, ÀÎÁõÀÇ. ¼ö·Ã»ý. ¿¬±¸¿ø µî 3¸¸¿ø (ÇöÀåµî·Ï) »çÀüµî·Ïºñ +1¸¸¿ø, Æò»ýȸ¿øÀº ¸éÁ¦ * Çмú´ëȸ A·ë, ¿¬¼ö±³À° B·ë¿¡¼ µ¿½Ã ÁøÇà
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 09:10~09:35 Prediction of the Mortality Risk in Peritoneal Dialysis Patients using Machine Learning Models: A Nation-wide Prospective Cohort in Korea ÀÌÁ¤Ç¥(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 09:35~10:00 Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer¡¯s Disease °û¼¼¿(ºÎ»ê´ë ½É¸®Çаú)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 10:00~10:25 Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer °½Â¿Ï(¼¿ï´ë °£È£Çаú)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 10:25~10:50 Genome-wide association study of occupational attainment as a proxy for cognitive reserve ¸í¿ìÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 10:50~11:00 Q & A ()
ÈÞ½Ä 05-13 ÄÁº¥¼ÇȦ A 11:00~11:10 Coffee Break ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A, B 11:10~11:50 PS: Digital healthcare: Global big tech movement ȲÈñ(Ä«Ä«¿ÀÇコÄÉ¾î ´ëÇ¥)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 11:50~12:30 Aricept, the Standard of Care within the Advances of AD treatment ÀÌ¿µ¹Î(ºÎ»êÀÇ´ë)
ÈÞ½Ä 05-13 ÄÁº¥¼ÇȦ A 12:30~13:00 Break ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 13:00~13:25 Global trend of metaverse-based digital therapeutics Á¤Å¸í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 13:25~13:50 VR-based stress reduction program ÀüÈ«Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 13:50~14:15 VR-based cognitive behavioral therapy ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 14:15~14:40 VR-based cognitive training in older adults Á¶¼ºÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 14:40~14:50 Q & A ()
ÈÞ½Ä 05-13 ÄÁº¥¼ÇȦ A 14:50~15:00 Coffee break ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 15:00~15:25 Sound/ultrasound gamma entrainment therapy and its potential roles in neuroglia ±èÅÂ(GIST)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 15:25~15:50 Optimal conditions for entraining gamma waves using sensory stimulation in the human brain ¹Ú¿¹½Â(¼¿ï´ë ³úÀÎÁö°úÇаú)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 15:50~16:15 Neurobiological basis of tDCS in mild cognitive impairment and Alzheimer¡¯s disease °µ¿¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 16:15~16:40 Light to modulate brain ±èÀç°ü(GIST)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ A 16:40~16:50 Q & A ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 09:10~09:40 ³ëÀÎ ºÒ¸éÁõ Æò°¡ ¹× Ä¡·á ÃÖÀç¿ø(À»ÁöÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 09:40~10:10 ³ëÀÎ ·½¼ö¸éÇൿÀå¾Ö Æò°¡ ¹× Ä¡·á À±È£°æ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 10:10~10:40 ³ëÀÎ ÇÏÁöºÒ¾ÈÁõÈıº Æò°¡ ¹× Ä¡·á ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 10:40~11:00 Q & A ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 11:50~12:30 Optimal treatment strategy with more practical dosing of memantine in AD ±è½Å°â(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 13:00~13:25 Á¤½ÅÁõ°ú °ø°ÝÀû Çൿ(psychosis and aggression)ÀÇ Æò°¡ ¹× °ü¸® ¼Õ»óÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 13:25~13:50 ¿ì¿ïÁõ°ú ¹«°ü½É(depression and apathy)ÀÇ Æò°¡ ¹× °ü¸® ½Åö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 13:50~14:15 ¹èȸ¿Í ¾ÈÀýºÎÀý(wandering and restlessness)ÀÇ Æò°¡ ¹× °ü¸® À±Çöö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 14:15~14:40 ½ÄÀ̺¯È¿Í ¾ß°£Çൿ(eating and night-time disturbance)ÀÇ Æò°¡ ¹× °ü¸® ÁÖ¼öÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 14:40~14:50 Q & A ()
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 15:00~15:30 ³ëÀÎ »ó´ã ½Ã ´Ù·ç¾î¾ß ÇÒ ½É¸®»çȸÀû À̽´ ±èº´¼ö(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 15:30~16:00 Áø·á½Ç¿¡¼ ÇÒ ¼ö ÀÖ´Â ³ëÀÎÁ¤½ÅÄ¡·á ±â¹ý ÇѱԸ¸(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 16:00~16:30 ÀÎÁöÀúÇÏ ³ëÀΠȯÀÚ¸¦ À§ÇÑ Á¤½ÅÄ¡·á ¿À´ëÁ¾(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-13 ÄÁº¥¼ÇȦ B 16:30~16:50 Q & A ()
±âŸ 05-13 ÄÁº¥¼ÇȦ A, B 16:50~17:00 ÀÎÁõÀÇ ¹× ¿ì¼ö Æ÷½ºÅÍ ½Ã»ó½Ä ()